Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PDT for Cervical HPV and CIN
NCT02304770Phase 2Completed
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Started Jan 2015; status: completed.
02
Drugs
aminolevulinic acid
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT02304770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304770.